Background The proportion of patients infected with SARS-CoV-2 that are prescribed
antibiotics is uncertain, and may contribute to patient harm and global antibiotic resistance …

Aim COVID-19 clinical presentation is heterogeneous, ranging from asymptomatic to severe
cases. While there are a number of early publications relating to risk factors for COVID-19 …

The presence of SARS-CoV-2 was officially documented in Europe at the end of February
2020. Despite many observations, the real impact of COVID-19 in the European Union (EU) …

Introduction Progression of COVID-19 to severe disease and death is insufficiently
understood. Objective Summarize the prevalence of risk factors and adverse outcomes and …

Background Coronaviruses mainly affect the respiratory system; however, there are reports
of SARS-CoV and MERS-CoV causing neurological manifestations. We aimed at discussing …

Objectives The acute respiratory distress syndrome (ARDS) secondary to viral pneumonitis
is one of the main causes of high mortality in patients with COVID-19 (novel coronavirus …

Rationale & Objective Coronavirus disease 2019 (COVID-19) may be associated with high
rates of acute kidney injury (AKI) and kidney replacement therapy (KRT), potentially …

Background Different proportions of musculoskeletal or autoimmune manifestations
associated with COVID-19 have been reported in literature. We performed a systematic …

Background Acute kidney injury (AKI) can affect hospitalized patients with coronavirus
disease 2019 (COVID-19), with estimates ranging between 0.5% and 40%. We performed a …

We aimed to study the mechanism behind worse coronavirus disease-19 (COVID-19)
outcomes in men and whether the differences between sexes regarding mortality as well as …